MOLN
Price
$3.76
Change
+$0.04 (+1.08%)
Updated
Jul 7, 10:30 AM (EDT)
Capitalization
137.67M
49 days until earnings call
PULM
Price
$6.78
Change
+$0.25 (+3.83%)
Updated
Jul 7, 12:03 PM (EDT)
Capitalization
23.85M
30 days until earnings call
Interact to see
Advertisement

MOLN vs PULM

Header iconMOLN vs PULM Comparison
Open Charts MOLN vs PULMBanner chart's image
Molecular Partners AG
Price$3.76
Change+$0.04 (+1.08%)
Volume$132
Capitalization137.67M
Pulmatrix
Price$6.78
Change+$0.25 (+3.83%)
Volume$571
Capitalization23.85M
MOLN vs PULM Comparison Chart in %
Loading...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MOLN vs. PULM commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOLN is a Hold and PULM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (MOLN: $3.76 vs. PULM: $6.53)
Brand notoriety: MOLN and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MOLN: 18% vs. PULM: 41%
Market capitalization -- MOLN: $137.67M vs. PULM: $23.85M
MOLN [@Biotechnology] is valued at $137.67M. PULM’s [@Biotechnology] market capitalization is $23.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MOLN’s FA Score shows that 1 FA rating(s) are green whilePULM’s FA Score has 0 green FA rating(s).

  • MOLN’s FA Score: 1 green, 4 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, PULM is a better buy in the long-term than MOLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MOLN’s TA Score shows that 3 TA indicator(s) are bullish while PULM’s TA Score has 3 bullish TA indicator(s).

  • MOLN’s TA Score: 3 bullish, 3 bearish.
  • PULM’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, MOLN is a better buy in the short-term than PULM.

Price Growth

MOLN (@Biotechnology) experienced а +5.03% price change this week, while PULM (@Biotechnology) price change was -6.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.61%. For the same industry, the average monthly price growth was +13.95%, and the average quarterly price growth was -0.52%.

Reported Earning Dates

MOLN is expected to report earnings on Aug 25, 2025.

PULM is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+5.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($138M) has a higher market cap than PULM($23.8M). PULM YTD gains are higher at: -6.447 vs. MOLN (-20.809). PULM has higher annual earnings (EBITDA): -9.58M vs. MOLN (-57.15M). MOLN has more cash in the bank: 131M vs. PULM (7.71M). PULM has less debt than MOLN: PULM (0) vs MOLN (2.14M). MOLN has higher revenues than PULM: MOLN (2.23M) vs PULM (1.92M).
MOLNPULMMOLN / PULM
Capitalization138M23.8M580%
EBITDA-57.15M-9.58M597%
Gain YTD-20.809-6.447323%
P/E RatioN/AN/A-
Revenue2.23M1.92M116%
Total Cash131M7.71M1,700%
Total Debt2.14M0-
FUNDAMENTALS RATINGS
PULM: Fundamental Ratings
PULM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MOLNPULM
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bullish Trend 5 days ago
72%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
69%
Bearish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
68%
Bullish Trend 11 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPEA0.080.01
+20.08%
Kun Peng International Ltd.
KPTCY6.85N/A
N/A
Kansai Paint Co., Ltd.
OCGPF2.65N/A
N/A
Oceana Group Ltd.
KRYAY109.31-1.29
-1.17%
Kerry Group plc
CYTOF0.08-0.02
-20.97%
Altamira Therapeutics Ltd.

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
N/A
SNSE - MOLN
41%
Loosely correlated
-2.54%
ATRA - MOLN
34%
Loosely correlated
+2.61%
HURA - MOLN
30%
Poorly correlated
+0.40%
BIORQ - MOLN
28%
Poorly correlated
-6.25%
ADXN - MOLN
26%
Poorly correlated
+2.68%
More

PULM and

Correlation & Price change

A.I.dvisor tells us that PULM and INM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PULM and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
-6.71%
INM - PULM
29%
Poorly correlated
-4.59%
CRIS - PULM
24%
Poorly correlated
+3.43%
CERO - PULM
23%
Poorly correlated
-2.11%
MOLN - PULM
23%
Poorly correlated
N/A
OBIO - PULM
22%
Poorly correlated
+0.35%
More